<p>ERα36 as a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway</p> - Concepedia

Concepedia

Publication | Open Access

<p>ERα36 as a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway</p>

DOI Full Paper Access

20

Citations

26

References

2020

Year

Guangliang Li, Jing Zhang, Zhenzhen Xu, Zhongqi Li

Cancer Management and Research

Abstract

Knockdown of ERα36 inhibits the growth of MCF-7/TAM cells in vitro and in vivo by blocking EGFR/ERK signaling pathway. ERα36 may be a candidate therapeutic target for the treatment of tamoxifen-resistant breast cancer.

References

	Year	Citations

Page 1